Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea

Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Brain Neoplasms

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Brain Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bacin, F; Cellarier, E; Chollet, P; D'Incan, M; Durando, X; Farges, MC; Madelmont, JC; Mouret-Reynier, MA; Thivat, E; Vasson, MP	1
Bay, JO; Chazal, J; Chollet, P; Curé, H; Durando, X; Lemaire, JJ; Lentz, MA; Roché, H; Thivat, E; Verrelle, P	1
Barthomeuf, C; Cellarier, E; Chollet, P; D'Incan, M; Demidem, A; Durando, X; Farges, MC; Thivat, E; Vasson, MP	1
Adenis, A; Chollet, P; Cure, H; Fargeot, P; Fumoleau, P; Hanausk, A; Lentz, MA; Madelmont, JC; Roche, H; Terret, C	1

Trials

4 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Brain Neoplasms

Article	Year
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diet; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Melanoma; Methionine; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Nutritional Status; Prognosis; Survival Rate; Treatment Outcome	2009
Cystemustine in recurrent high grade glioma. Journal of neuro-oncology, 2006, Volume: 79, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Prognosis; Survival Analysis; Survival Rate; Treatment Outcome	2006
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial. Nutrition and cancer, 2008, Volume: 60, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Melanoma; Methionine; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Nutritional Status; Oligodendroglioma; Patient Compliance; Treatment Outcome	2008
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults. Journal of neuro-oncology, 2000, Volume: 49, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; Thrombocytopenia; Tomography, X-Ray Computed	2000